Question 1

Has Julie Larkin, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $336 in general payments to Julie Larkin, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Julie Larkin, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Julie Larkin, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Astellas Pharma US Inc	3	$172
Insmed, Inc.	4	$118
Aimmune Therapeutics, Inc.	2	$46

Drug	Claims	Cost to plans & patients
Daptomycin	32	$27,157
ErtapenemErtapenem Sodium	11	$7,496
Cefepime Hcl	38	$6,236
Meropenem	13	$3,645
Vancomycin Hcl	25	$2,836
CeftriaxoneCeftriaxone Sodium	34	$2,529
Cephalexin	98	$1,957
CefuroximeCefuroxime Axetil	31	$954
Doxycycline Hyclate	37	$784
Cefazolin Sodium	14	$711
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	24	$467
Amoxicillin	23	$461
Fluconazole	21	$424
Ciprofloxacin Hcl	19	$361
Ethambutol Hcl	14	$319

Julie Larkin, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other infectious disease in Sarasota